QC
TARA icon

Quadrature Capital’s Protara Therapeutics TARA Stock Holding History

Quadrature Capital’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
+39,319
New +$187K ﹤0.01% 1415
2026
Q1 		– Sell
-24,184
Closed -$129K – 1840
2025
Q4 		$129K Buy
24,184
+6,838
+39% +$38K ﹤0.01% 1059
2025
Q3 		$75.1K Buy
17,346
+5,755
+50% +$18.6K ﹤0.01% 916
2025
Q2 		$35.2K Buy
+11,591
New +$40K ﹤0.01% 977

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Quadrature Capital's TARA Position: Q2 2026 in Review

Quadrature Capital opened a new position in Protara Therapeutics (TARA) in Q2 2026: 39,319 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #1415 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in TARA as recently as Q4 2025.

Quadrature Capital first reported a position in TARA in Q2 2025 and has held it in 4 quarters since. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Quadrature Capital held 39,319 shares of Protara Therapeutics worth $150K as of Q2 2026.
  • Protara Therapeutics was a new Quadrature Capital position in Q2 2026.
  • Protara Therapeutics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1415 holding.
  • Quadrature Capital first reported a position in Protara Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.